143 related articles for article (PubMed ID: 8415815)
1. The 5-HT3 antagonist zacopride attenuates cocaine-induced increases in extracellular dopamine in rat nucleus accumbens.
McNeish CS; Svingos AL; Hitzemann R; Strecker RE
Pharmacol Biochem Behav; 1993 Aug; 45(4):759-63. PubMed ID: 8415815
[TBL] [Abstract][Full Text] [Related]
2. Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens.
Chen JP; van Praag HM; Gardner EL
Brain Res; 1991 Mar; 543(2):354-7. PubMed ID: 1711914
[TBL] [Abstract][Full Text] [Related]
3. Selective reduction of extracellular dopamine in the rat nucleus accumbens following chronic treatment with DAU 6215, a 5-HT3 receptor antagonist.
Invernizzi R; Pozzi L; Samanin R
Neuropharmacology; 1995 Feb; 34(2):211-5. PubMed ID: 7617146
[TBL] [Abstract][Full Text] [Related]
4. 5-HT3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism.
Svingos AL; Hitzemann R
Pharmacol Biochem Behav; 1992 Nov; 43(3):871-9. PubMed ID: 1448481
[TBL] [Abstract][Full Text] [Related]
5. 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice.
Reith ME
Eur J Pharmacol; 1990 Sep; 186(2-3):327-30. PubMed ID: 2289534
[TBL] [Abstract][Full Text] [Related]
6. The selective serotonin(1A)-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase.
Müller CP; De Souza Silva MA; DePalma G; Tomaz C; Carey RJ; Huston JP
Behav Brain Res; 2002 Aug; 134(1-2):337-46. PubMed ID: 12191821
[TBL] [Abstract][Full Text] [Related]
7. Neurotensin increases extracellular striatal dopamine levels in vivo.
Chapman MA; See RE; Bissette G
Neuropeptides; 1992 Jul; 22(3):175-83. PubMed ID: 1436404
[TBL] [Abstract][Full Text] [Related]
8. 5-HT3 receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens of rats.
Cervo L; Pozzi L; Samanin R
Pharmacol Biochem Behav; 1996 Sep; 55(1):33-7. PubMed ID: 8870035
[TBL] [Abstract][Full Text] [Related]
9. Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine.
Benwell ME; Balfour DJ; Lucchi HM
Psychopharmacology (Berl); 1993; 112(4):467-74. PubMed ID: 7871059
[TBL] [Abstract][Full Text] [Related]
10. Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens.
Kalivas PW; Duffy P
Synapse; 1990; 5(1):48-58. PubMed ID: 2300906
[TBL] [Abstract][Full Text] [Related]
11. Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens.
Campbell AD; McBride WJ
Pharmacol Biochem Behav; 1995 Aug; 51(4):835-42. PubMed ID: 7675866
[TBL] [Abstract][Full Text] [Related]
12. Carbamazepine attenuates cocaine-induced increases in dopamine in the nucleus accumbens: an in vivo dialysis study.
Baptista T; Weiss SR; Post RM
Eur J Pharmacol; 1993 May; 236(1):39-42. PubMed ID: 8319744
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens.
Rakovska A; Baranyi M; Windisch K; Petkova-Kirova P; Gagov H; Kalfin R
Brain Res Bull; 2017 Sep; 134():246-252. PubMed ID: 28802898
[TBL] [Abstract][Full Text] [Related]
14. Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow.
Koeltzow TE; Austin JD; Vezina P
Neuropharmacology; 2003 Jan; 44(1):102-10. PubMed ID: 12559127
[TBL] [Abstract][Full Text] [Related]
15. Extracellular dopamine and its metabolites in the nucleus accumbens of Fischer and Lewis rats: basal levels and cocaine-induced changes.
Strecker RE; Eberle WF; Ashby CR
Life Sci; 1995; 56(6):PL135-41. PubMed ID: 7530315
[TBL] [Abstract][Full Text] [Related]
16. Decreased accumbens dopamine release after cocaine challenge in behaviorally sensitized female rats.
Johnson DW; Eodice P; Winterbottom H; Mokler DJ
Pharmacol Biochem Behav; 2000 Apr; 65(4):659-64. PubMed ID: 10764919
[TBL] [Abstract][Full Text] [Related]
17. 5-HT3 receptor antagonists attenuate dopamine-induced hyperactivity in the rat.
Costall B; Domeney AM; Naylor RJ
Neuroreport; 1990 Sep; 1(1):77-80. PubMed ID: 1966601
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a novel tropane analog of cocaine, 2 beta-propanoyl-3 beta-(4-tolyl) tropane with cocaine HCl in rats: nucleus accumbens extracellular dopamine concentration and motor activity.
Hemby SE; Co C; Reboussin D; Davies HM; Dworkin SI; Smith JE
J Pharmacol Exp Ther; 1995 May; 273(2):656-66. PubMed ID: 7752068
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic dopamine release is enhanced by 5-HT3 receptor activation in medial prefrontal cortex of freely moving rats.
Chen J; Paredes W; Van Praag HM; Lowinson JH; Gardner EL
Synapse; 1992 Mar; 10(3):264-6. PubMed ID: 1557698
[No Abstract] [Full Text] [Related]
20. MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens.
Wolf ME; Xue CJ; White FJ; Dahlin SL
Brain Res; 1994 Dec; 666(2):223-31. PubMed ID: 7882032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
